Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “RSV Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT04980391
What this trial is testing

A Study on the Safety and Immune Response to an Unadjuvanted RSV Maternal Vaccine, in High Risk Pregnant Women Aged 15 to 49 Years and Infants Born to the Vaccinated Mothers

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 384
Early research (Phase 1)Study completedNCT01905215
What this trial is testing

Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccines

Who this might be right for
Infections, Respiratory Syncytial Virus
GlaxoSmithKline 128
Not applicableStudy completedNCT02016690
What this trial is testing

Synagis® Liquid 50mg, 100mg for Intramuscular Injection Special Investigation in Immunocompromised Children With Synagis®

Who this might be right for
Respiratory Syncytial Virus Infection
AbbVie 312
Not applicableStudy completedNCT06743750
What this trial is testing

Comparison Between Different Sampling Sites for Detection of Respiratory Viruses

Who this might be right for
Respiratory Tract Infection Viral
Insel Gruppe AG, University Hospital Bern 501
Early research (Phase 1)Active Not RecruitingNCT04896853
What this trial is testing

Treatment of Respiratory Complications Associated With COVID19,Influenza ,Metapneumovirus,RSV Infection Using ProTrans®

Who this might be right for
COVID-19 Acute Respiratory Distress SyndromeInfluenza AMetapneumovirus Pneumonia+1 more
NextCell Pharma Ab 9
Testing effectiveness (Phase 2)Study completedNCT03691623
What this trial is testing

A Phase 2a Study to Evaluate EDP-938 in the Virus Challenge Model

Who this might be right for
RSV Infection
Enanta Pharmaceuticals, Inc 179
Not applicableStudy completedNCT03757429
What this trial is testing

Inflammatory Mediators Associated With Infection by Respiratory Syncytial Virus

Who this might be right for
Respiratory Tract InfectionsRespiratory Syncytial Virus Infections
Uppsala University 31
Testing effectiveness (Phase 2)Ended earlyNCT03715023
What this trial is testing

Anti-viral Effect of PC786 on RSV Infection on HSCT Recipients

Who this might be right for
Respiratory Syncytial Virus Infections
Pulmocide Ltd 5
Not applicableEnded earlyNCT04431050
What this trial is testing

Evaluation of a Single Use Point of Care Device for the Diagnosis of Respiratory Pathogens

Who this might be right for
Human InfluenzaRespiratory Syncytial Virus InfectionsRhinoviral Infections+3 more
Imperial College London 6
Early research (Phase 1)Study completedNCT06847464
What this trial is testing

A Drug-Drug Interaction Study to Evaluate the Effects of Itraconazole, Carbamazepine, Quinidine and Fluconazole on the Pharmacokinetics and Safety of EDP-323.

Who this might be right for
RSV InfectionDrug Drug Interaction (DDI)
Enanta Pharmaceuticals, Inc 48
Testing effectiveness (Phase 2)Study completedNCT04071158
What this trial is testing

A RSV VACCINE WHEN GIVEN TOGETHER WITH TDAP IN HEALTHY NONPREGNANT WOMEN AGED BETWEEN 18 TO 49 YEARS

Who this might be right for
Respiratory Tract Infection
Pfizer 713
Post-approval studies (Phase 4)Study completedNCT02571517
What this trial is testing

Glucocorticoid Therapy Impact on the Inflammatory Response and Clinical Evolution in Patients With Severe Bronchiolitis

Who this might be right for
Bronchiolitis, Viral
Fundació Sant Joan de Déu 94
Not applicableStudy completedNCT07177508
What this trial is testing

First Year Impact of Nirsevimab on Paediatric Respiratory Syncytial Virus Infection and Hospitalisations in the Australian Capital Territory

Who this might be right for
Respiratory Syncytial Viral (RSV) InfectionRespiratory Syncytial Virus HospitalizationsRespiratory Syncytial Virus Prevention
Nicola Irwin 2,355
Not applicableUnknownNCT06259487
What this trial is testing

Coordinated Vaccination Against RSV and Influenza in Patients With Chronic Heart Failure and Its Impact on Prognosis.

Who this might be right for
Heart FailureRSV InfectionInfluenza+1 more
Wroclaw Medical University 250
Large-scale testing (Phase 3)Active Not RecruitingNCT07220109
What this trial is testing

A Study on the Immune Response and Safety of Vaccine Against Respiratory Syncytial Virus Given to Chinese Adults 18 to 59 Years of Age at Increased Risk of Respiratory Syncytial Virus Disease

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 750
Not applicableStudy completedNCT00593918
What this trial is testing

Innate Immunity and Respiratory Syncytial Virus (RSV) Infection in Children

Who this might be right for
Respiratory Syncytial Virus Infection
University of Wisconsin, Madison 91
Not applicableActive Not RecruitingNCT05864118
What this trial is testing

Comparison of Nasopharyngeal Swab v. Nasopharyngeal Saline Wash or Saliva Collection in Testing for Respiratory Viruses

Who this might be right for
Respiratory Tract Infections
University of Nebraska 1,000
Not applicableNot Yet RecruitingNCT07015255
What this trial is testing

Assessing the Burden of Respiratory Syncytial Virus (RSV)

Who this might be right for
Respiratory Syncytial Virus (RSV) InfectionAcute Lower Respiratory Tract InfectionsBronchiolitis+2 more
Abu Dhabi Health Services Company 1,500
Large-scale testing (Phase 3)Study completedNCT04424316
What this trial is testing

A Trial to Evaluate the Efficacy and Safety of RSVpreF in Infants Born to Women Vaccinated During Pregnancy.

Who this might be right for
Respiratory Tract Infection
Pfizer 14,727
Early research (Phase 1)Study completedNCT04065698
What this trial is testing

Pharmacokinetics and Safety of RV521 Formulations

Who this might be right for
Respiratory Syncytial Virus Infections
Pfizer 9
Next Page